Evommune, Inc. (EVMN) SEC Filings https://ir.evommune.com/financial-information/sec-filings/rss Evommune, Inc. (EVMN) - SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/_2094dba4d31887f5c3cda4773c265127/evommune/files/theme/images/logo-sm.png Evommune, Inc. Logo Equisolve Investor Relations Suite <![CDATA[144 - Report of proposed sale of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001950047-26-006381/0001950047-26-006381.pdf Mon, 22 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001950047-26-006381/0001950047-26-006381.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001216994-26-000003/0001216994-26-000003.pdf Wed, 03 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001216994-26-000003/0001216994-26-000003.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001290976-26-000002/0001290976-26-000002.pdf Wed, 03 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001290976-26-000002/0001290976-26-000002.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001347383-26-000003/0001347383-26-000003.pdf Wed, 03 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001347383-26-000003/0001347383-26-000003.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0002092017-26-000005/0002092017-26-000005.pdf Wed, 03 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0002092017-26-000005/0002092017-26-000005.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000005/0001620548-26-000005.pdf Wed, 03 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001620548-26-000005/0001620548-26-000005.pdf <![CDATA[144 - Report of proposed sale of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001950047-26-005513/0001950047-26-005513.pdf Tue, 02 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001950047-26-005513/0001950047-26-005513.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-253489/0001193125-26-253489.pdf Tue, 02 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-253489/0001193125-26-253489.pdf <![CDATA[8-K - Current report]]> https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-253482/0001193125-26-253482.pdf Tue, 02 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001193125-26-253482/0001193125-26-253482.pdf <![CDATA[4 - Statement of changes in beneficial ownership of securities]]> https://ir.evommune.com/financial-information/sec-filings/content/0001742496-26-000005/0001742496-26-000005.pdf Mon, 01 Jun 26 00:00:00 -0400 https://ir.evommune.com/financial-information/sec-filings/content/0001742496-26-000005/0001742496-26-000005.pdf